EP0147716A3
(de)
|
1983-12-24 |
1987-10-28 |
ANT Nachrichtentechnik GmbH |
Verfahren und Anordnung zur verschlüsselbaren Übertragung einer Nachrichten-Binärzeichenfolge mit Authentizitätsprüfung
|
JPS6235216A
(ja)
|
1985-08-09 |
1987-02-16 |
Noritoshi Nakabachi |
不均質物質層の層厚非破壊測定方法および装置
|
US5187157A
(en)
|
1987-06-05 |
1993-02-16 |
Du Pont Merck Pharmaceutical Company |
Peptide boronic acid inhibitors of trypsin-like proteases
|
GR1001529B
(el)
|
1990-09-07 |
1994-03-31 |
Elmuquimica Farm Sl |
Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
|
GB9019558D0
(en)
|
1990-09-07 |
1990-10-24 |
Szelke Michael |
Enzyme inhibitors
|
WO1993018007A1
(en)
|
1992-03-13 |
1993-09-16 |
Tokyo Tanabe Company Limited |
Novel carbostyril derivative
|
SE9301911D0
(sv)
|
1993-06-03 |
1993-06-03 |
Ab Astra |
New peptide derivatives
|
US5464820A
(en)
|
1993-06-22 |
1995-11-07 |
The University Hospital |
Specific inhibitors of tissue kallikrein
|
GB9318637D0
(en)
|
1993-09-08 |
1993-10-27 |
Ferring Res Ltd |
Enzyme inhibitors
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
US6683115B2
(en)
|
1999-06-02 |
2004-01-27 |
Theravance, Inc. |
β2-adrenergic receptor agonists
|
OA11558A
(en)
|
1999-12-08 |
2004-06-03 |
Advanced Medicine Inc |
Beta 2-adrenergic receptor agonists.
|
EE200200602A
(et)
|
2000-04-27 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pikatoimelised beetamimeetikumid, meetod nende valmistamiseks ja nende kasutamine ravimitena
|
GB0015876D0
(en)
|
2000-06-28 |
2000-08-23 |
Novartis Ag |
Organic compounds
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
JP2004526720A
(ja)
|
2001-03-08 |
2004-09-02 |
グラクソ グループ リミテッド |
βアドレナリン受容体のアゴニスト
|
DE60224172T2
(de)
|
2001-03-22 |
2008-12-04 |
Glaxo Group Ltd., Greenford |
Formanilid-derivative als beta2-adrenorezeptor-agonisten
|
PL211953B1
(pl)
|
2001-09-14 |
2012-07-31 |
Glaxo Group Ltd |
Pochodna fenetanoloaminy, zawierający ją środek farmaceutyczny i zastosowanie pochodnej fenetanoloaminy
|
TWI249515B
(en)
|
2001-11-13 |
2006-02-21 |
Theravance Inc |
Aryl aniline beta2 adrenergic receptor agonists
|
US6653323B2
(en)
|
2001-11-13 |
2003-11-25 |
Theravance, Inc. |
Aryl aniline β2 adrenergic receptor agonists
|
ES2271365T3
(es)
|
2001-12-20 |
2007-04-16 |
Bayer Healthcare Ag |
Derivados de 1,4-dihidro-1,4-difenilpiridina.
|
GB0204719D0
(en)
|
2002-02-28 |
2002-04-17 |
Glaxo Group Ltd |
Medicinal compounds
|
AU2003222841A1
(en)
|
2002-04-25 |
2003-11-10 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
AU2003239880A1
(en)
|
2002-05-28 |
2003-12-12 |
Theravance, Inc. |
ALKOXY ARYL Beta2 ADRENERGIC RECEPTOR AGONISTS
|
WO2003101941A2
(en)
|
2002-05-31 |
2003-12-11 |
Genzyme Corporation |
Alpha acyloxyacetamides for kallikrein and urokinase inhibition
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
AR040962A1
(es)
|
2002-08-09 |
2005-04-27 |
Novartis Ag |
Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
|
DE60315862T2
(de)
|
2002-08-27 |
2008-05-15 |
Bayer Healthcare Ag |
Dihydropyridinonderivate als hne-inhibitoren
|
GB0219896D0
(en)
|
2002-08-27 |
2002-10-02 |
Bayer Ag |
Dihydropyridine derivatives
|
GB0220730D0
(en)
|
2002-09-06 |
2002-10-16 |
Glaxo Group Ltd |
Medicinal compounds
|
CA2498052C
(en)
|
2002-09-10 |
2011-05-17 |
Bayer Healthcare Ag |
Heterocyclic derivatives
|
EP1546113B1
(en)
|
2002-09-10 |
2013-05-01 |
Bayer Intellectual Property GmbH |
Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
|
DE10246374A1
(de)
|
2002-10-04 |
2004-04-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
EP1440966A1
(en)
|
2003-01-10 |
2004-07-28 |
Pfizer Limited |
Indole derivatives useful for the treatment of diseases
|
CA2499314C
(en)
|
2002-10-11 |
2010-08-24 |
Pfizer Inc. |
Indole derivatives as beta-2 agonists
|
ES2291733T3
(es)
|
2002-10-22 |
2008-03-01 |
Glaxo Group Limited |
Compuestos de ariletanolamina medicinales.
|
NZ539676A
(en)
|
2002-10-28 |
2006-10-27 |
Glaxo Group Ltd |
Phenethanolamine derivative for the treatment of respiratory diseases
|
GB0225030D0
(en)
|
2002-10-28 |
2002-12-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225535D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0225540D0
(en)
|
2002-11-01 |
2002-12-11 |
Glaxo Group Ltd |
Medicinal compounds
|
JP2004161702A
(ja)
|
2002-11-14 |
2004-06-10 |
Hokko Chem Ind Co Ltd |
γ−ジャスモラクトンの製造方法
|
US7056916B2
(en)
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
DE10253282A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
DE10253220A1
(de)
|
2002-11-15 |
2004-05-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE10258695A1
(de)
|
2002-12-16 |
2004-06-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neuer, langwirksamer Beta-agonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
EP1460064A1
(en)
|
2003-03-14 |
2004-09-22 |
Pfizer Limited |
Indole-2-carboxamide derivatives useful as beta-2 agonists
|
EP1615881A2
(en)
|
2003-04-01 |
2006-01-18 |
Theravance, Inc. |
Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
|
PT1613315E
(pt)
|
2003-04-04 |
2009-04-22 |
Novartis Ag |
Derivados da quinolina-2-ona para o tratamento de doenças das vias aéreas respiratórias
|
US7268147B2
(en)
|
2003-05-15 |
2007-09-11 |
Pfizer Inc |
Compounds useful for the treatment of diseases
|
EP1626970B1
(en)
|
2003-05-28 |
2009-07-08 |
Theravance, Inc. |
Azabicycloalkane compounds as muscarinic receptor antagonists
|
ES2298757T3
(es)
|
2003-06-04 |
2008-05-16 |
Pfizer Inc. |
Derivados de z-amino-piridina como agonistas de adrecorreceptores beta-2.
|
GB0312832D0
(en)
|
2003-06-04 |
2003-07-09 |
Pfizer Ltd |
2-amino-pyridine derivatives useful for the treatment of diseases
|
SE0302323D0
(sv)
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302324D0
(sv)
|
2003-08-28 |
2003-08-28 |
Astrazeneca Ab |
Novel compounds
|
SE0302487D0
(sv)
|
2003-09-18 |
2003-09-18 |
Astrazeneca Ab |
Novel compounds
|
SE0302486D0
(sv)
|
2003-09-18 |
2003-09-18 |
Astrazeneca Ab |
Novel compounds
|
WO2005033121A2
(en)
|
2003-10-03 |
2005-04-14 |
King Pharmaceuticals Research & Development, Inc. |
Synthesis of 2-aralkyloxyadenosines, 2-alkoxyadenosines, and their analogs
|
GB0323701D0
(en)
|
2003-10-09 |
2003-11-12 |
Glaxo Group Ltd |
Formulations
|
GB0324654D0
(en)
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
CN100450488C
(zh)
|
2003-11-03 |
2009-01-14 |
诺顿·希尔思凯尔有限公司 |
用于干粉吸入剂的软类固醇组合物
|
GB0328490D0
(en)
|
2003-12-09 |
2004-01-14 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
US7807046B2
(en)
|
2003-12-19 |
2010-10-05 |
Shell Oil Company |
Systems, methods, and catalysts for producing a crude product
|
DE102004001413A1
(de)
|
2004-01-09 |
2005-08-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
3-Hydroxymethyl-4-Hydroxy-Phenyl-Derivate zur Behandlung von chronisch obstruktiver Lungenerkrankung
|
TW200531692A
(en)
|
2004-01-12 |
2005-10-01 |
Theravance Inc |
Aryl aniline derivatives as β2 adrenergic receptor agonists
|
EA009735B1
(ru)
|
2004-01-22 |
2008-02-28 |
Пфайзер Инк. |
Сульфонамидные производные для лечения заболеваний
|
AU2005214153B2
(en)
|
2004-01-22 |
2008-09-18 |
Pfizer Inc. |
Sulfonamide derivatives for the treatment of diseases
|
DE102004003428A1
(de)
|
2004-01-23 |
2005-08-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel
|
DE502005010170D1
(de)
|
2004-02-14 |
2010-10-14 |
Boehringer Ingelheim Pharma |
Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
|
ATE516285T1
(de)
|
2004-02-19 |
2011-07-15 |
Bayer Schering Pharma Ag |
Dihydropyridinonderivate
|
ES2394177T3
(es)
|
2004-02-26 |
2013-01-23 |
Bayer Intellectual Property Gmbh |
1,4-diaril-dihidropirimidin-2-onas y su uso como inhibidores de elastasa de neutrófilos humanos
|
US7893073B2
(en)
|
2004-02-26 |
2011-02-22 |
Bayer Schering Pharma Aktiengesellschaft |
Heterocyclic derivatives
|
WO2005092861A1
(en)
|
2004-03-11 |
2005-10-06 |
Pfizer Limited |
Quinolinone derivatives pharmaceutical compositions containing them and their use
|
EP1577306A1
(de)
|
2004-03-17 |
2005-09-21 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Neue Benzoxazinonderivate als langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
|
EP1577292A1
(en)
|
2004-03-17 |
2005-09-21 |
Pfizer Limited |
Phenylaminoethanol derivatives as beta2 receptor agonists
|
HN2004000023A
(es)
|
2004-03-22 |
2007-11-23 |
Mars Inc |
Mascadura para animales
|
WO2005092841A1
(en)
|
2004-03-23 |
2005-10-06 |
Pfizer Limited |
Compounds having beta-agonist activity
|
WO2005092860A1
(en)
|
2004-03-23 |
2005-10-06 |
Pfizer Limited |
Compounds for the treatment of diseases
|
JP4108117B2
(ja)
|
2004-03-23 |
2008-06-25 |
ファイザー・インク |
疾患を処置するための化合物
|
WO2005092840A1
(en)
|
2004-03-23 |
2005-10-06 |
Pfizer Limited |
Formamide derivatives useful as adrenoceptor
|
EP1736465A4
(en)
|
2004-03-31 |
2009-06-17 |
Ajinomoto Kk |
ANILINE DERIVATIVES
|
EP1595873A1
(de)
|
2004-05-13 |
2005-11-16 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
Substituierte Cycloalkylderivate zur Behandlung von Atemswegerkrankungen
|
CA2565243A1
(en)
|
2004-05-13 |
2005-11-24 |
Boehringer Ingelheim International Gmbh |
Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
|
DE102004024454A1
(de)
|
2004-05-14 |
2005-12-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
DE102004024451A1
(de)
|
2004-05-14 |
2005-12-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pulverformulierungen für die Inhalation, die Enantiomerenreine Betaagonisten enthalten
|
US20080039495A1
(en)
|
2004-06-03 |
2008-02-14 |
Linsell Martin S |
Diamine Beta2 Adrenergic Receptor Agonists
|
EP1778638A1
(en)
|
2004-07-21 |
2007-05-02 |
Theravance, Inc. |
Diaryl ether beta2 adrenergic receptor agonists
|
CA2575791A1
(en)
|
2004-08-03 |
2006-02-16 |
Dyax Corp. |
Hk1-binding proteins
|
WO2006016245A1
(en)
|
2004-08-05 |
2006-02-16 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
EP1786762A2
(en)
|
2004-09-10 |
2007-05-23 |
Theravance, Inc. |
Amidine substituted aryl aniline compounds
|
DE102004045648A1
(de)
|
2004-09-21 |
2006-03-23 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Betamimetika zur Behandlung von Atemwegserkrankungen
|
WO2006051373A1
(en)
|
2004-11-12 |
2006-05-18 |
Pfizer Limited |
Compounds for the treatment of diseases
|
GB0426164D0
(en)
|
2004-11-29 |
2004-12-29 |
Novartis Ag |
Organic compounds
|
JP5322935B2
(ja)
|
2006-07-31 |
2013-10-23 |
アクティベサイト ファーマシューティカルズ インコーポレイティッド |
血漿カリクレインの阻害薬
|